Insulet
Unternehmensprofil
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Beschreibung auf Englisch verfügbar.
Unternehmensdaten
- Branche
- Gesundheit
- Industrie
- Medical Devices
- Hauptsitz
- 100 Nagog Park, 01720, Acton
- Mitarbeitende
- 5.400
- Notierung
- PODD · NASDAQ
- Indizes
- S&P 500
- Währung
- USD
- ISIN
- US45784P1012
- Website
- insulet.com